Many times I am obviously too dumb to think of or anticipate developments with this stock but if I had to come up with something I would say this.
Here in the US there would have to be some legal victories, or possibly the introduction of an AG. Could there be some deal or arrangement with a statin mfr to market a combo?
Outside of the US it seems more reimbursement approvals and an acceleration of scripts in ROW would be a welcome positive.
Market Data 
Markets 
AI
